Detecting breast cancer in mammographically dense breasts: Comparing technetium-99m tetrofosmin mammoscintigraphy and ultrasonography

Cancer Investigation

Volumn 20, Issue 7-8, 2002, Pages 932-938

  Wang, Hwei Chung ^a   Chen, Dar Ren ^a   Kao, Chia Hung ^a   Lin, Cheng Chieh ^a   Lee, Cheng Chug ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Dense breast; Technetium 99m tetrofosmin; Ultrasonography

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; BREAST; BREAST BIOPSY; BREAST CANCER; BREAST TUMOR; CANCER SCREENING; CLINICAL ARTICLE; COMPARATIVE STUDY; DENSE BREAST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOMAMMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; PATHOLOGY; PRIORITY JOURNAL; SCINTILLATION CAMERA; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; TAIWAN; ULTRASOUND SCANNER;

ADENOCARCINOMA; ADULT; AGED; BREAST; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 0036417905     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120005907     Document Type: Article

References (24)

1. Kopans, D.B. The positive predictive value of mammography. Am. J. Radiol. 1992, 58, 521-526.
2. Bassett, L.W.; Liu, T.H.; Giuliano, A.E.; et al. The prevalence of carcinoma in palpable versus impalpable, mammographically detected lesions. Am. J. Radiol. 1991, 157, 21-24.
3. Moskowitz, M. The predictive value of certain mammographic signs in screening for breast cancer. Cancer 1983, 51, 1007-1011.
4. Sickles, E.A. Mammographic features of "early" breast cancer. Am. J. Radiol. 1984, 143, 461-464.
5. Lister, D.; Evans, A.J.; Burrell, H.C.; et al. The accuracy of breast ultrasound in the evaluation of clinically benign discrete, symptomatic breast lumps. Clin. Radiol. 1998, 53, 490-492.
6. Ciatto, S.; Rosselli del Turco, M.; Catarzi, S.; et al. The contribution of ultrasonography to the differential diagnosis of breast cancer. Neoplasma 1994, 41, 341-345.
7. Perre, C.I.; Koot, V.C.; de Hooge, P.: et al. The value of ultrasound in the evaluation of palpable breast tumours: A prospective study of 400 cases. Eur. J. Surg. Oncol. 1994, 20, 637-640.
8. Taillefer, R. The role of 99mtc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin. Nucl. Med. 1999, 29, 16-40.
9. Kao, C.H.; Wang, S.J.; Liu, T.J. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur. J. Nucl. Med. 1994, 21, 432-436.
10. Pollei, S.R.; Mettler, F.A., Jr. Bartow, S.A.; et al. Occult breast cancer: Prevalence and radiographic detectability. Radiology 1987, 163, 459-462.
11. Mann, B.D.; Giuliano, A.E.; Bassett, L.W.; et al. Delayed diagnosis of breast cancer as a result of normal mammograms. Arch. Surg. 1983, 118, 23-24.
12. Alagaratnam, T.T.; Wong, J. Limitations of mammography in Chinese females. Clin. Radiol. 1985, 36, 175-177.
13. Peer, P.G.M.; Verbeek, A.L.M.; Straatman, H.; et al. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res. Treat. 1996, 38, 153-160.
14. Kobayashi, T. Gray-scale echography for breast cancer. Radiology 1977, 122, 207-214.
15. Cole Beuglet, C.; Soriano, R.Z.; Kurtz, R.Z.; et al. Ultrasound analysis of 104 primary breast carcinomas classified according to histopathologic type. Radiology 1983, 147, 191-196.
16. Bernard, B.F.; Krenning, E.P.; Breeman, W.A.; et al. 99mTc-MIBI, 99mTc-Tetrofosmin and 99mTc-Q12 in vitro and in vivo. Nucl. Med. Biol. 1998, 25, 233-240.
17. Mansi, L.; Rambaldi, P.F.; Cuccurullo, V.; et al. Diagnostic and prognostic role of 99mtc-tetrofosmin in breast cancer. Q. J. Nucl. Med. 1997, 41, 239-250.
18. Rambaldi, P.F.; Mansi, L.; Procaccini, E.; et al. Breast cancer detection with Tc-99m tetrofosmin. Clin. Nucl. Med. 1995, 20, 703-705.
19. Barbarics, E.; Kronauge, J.F.; Cohen, D.; et al. Characterization of P-glycoprotein transport and inhibition in vivo. Cancer Res. 1998, 58, 276-282.
20. Ballinger, J.R.; Bannerman, J.; Boxen, I.; et al. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: In vitro studies in multidrug-resistant breast tumor cells. J. Nucl. Med. 1996, 37, 1578-1582.
21. Mansi, L.; Rambaldi, P.F.; Procaccinie; et al. Scingimammography with Technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur. J. Nucl. Med. 1996, 23, 932-939.
22. Markopoulos, C.; Sampalis, F.; Zerva, C.; et al. 99mTc Tetrofosmin Imaging in Breast Tumours. Eur. J. Gynaecol. Oncol. 1998, 19, 163-166.
23. Fenlon, H.M.; Phelan, N.C.; O'Sullivan, P.; et al. Benign versus malignant breast disease: Comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Radiology 1997, 205, 214-220.
24. Madariaga, P.; Almoguera, I.; Alonso, A.; et al. Technetium-99m Tetrofosmin Scintigraphy to Evaluate Breast Lesions. Anticancer Res. 1997, 17, 1619-1622.